Home / Digestive tract and metabolism / Butylscopolamine
ATC A03BB01 · Drugs for Functional Gastrointestinal Disorders
Butylscopolamine shortage
As of 31 Oct 2026, Butylscopolamine has a reported shortage in 2 of the 5 countries we track (Italy, Belgium), covering 2 products.
Countries2/5
Products2packs or presentations
Short since4 Jun 20265 months ago
Earliest return3 Nov 2026company estimate
No return date1products
Main reasonCommercial decision or withdrawal
Timeline
ItalyBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | BUTILSCOPOLAMINA LIVSANE | AUROBINDO PHARMA (ITALIA) S.R.L. | 4 Jun 2026 | not given | Commercial decision or withdrawal Motivi commerciali |
| BE | Buscopan 20 mg/ml inj. sol. i.m./i.v./s.c. amp. 6 x 1 ml | Opella Healthcare Belgium | 16 Oct 2026 | 3 Nov 2026 | Manufacturing problem Delay in the release of the end product |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.